The Tariff Problem Is Real. Here’s How to Play It. Every small-cap investor is asking the same question in May 2026: which companies actually survive the tariff cycle without getting clipped? The answer isn’t complicated. You find companies where revenue stays inside US borders — no Chinese supply chain, no export dependency, no “we’re monitoring …
Berkshire Hathaway just reported a record $397.4 billion in cash. The S&P 500 sits at 5,521, trading at a forward P/E of 20.9 — 28% above its 25-year average. And Warren Buffett called the current market a “casino.” We’re entering the weakest six-month stretch of the four-year presidential cycle. Here’s what the data says, what …
PBYI Stock Analysis: Puma Biotechnology Looks Cheap, but the Pipeline Still Has to Matter This PBYI stock analysis starts with the obvious part: Puma Biotechnology looks cheap on a screen. The company is profitable, it trades around 12x trailing earnings, it finished 2025 with $97.5 million in cash and marketable securities, and management is guiding …
Hudson Technologies is one of those small-cap stocks that sounds boring until you read the numbers and the regulations. That is why this HDSN stock analysis matters right now. Hudson sells and reclaims refrigerants, a niche business that benefits when the supply of virgin HFC refrigerants gets tighter under the AIM Act. At roughly a …
Alignment Healthcare reports Q1 2026 earnings after the bell today, April 30. The stock sits at $21.72 — roughly flat for the year. But the business has never grown this fast. Here are the numbers heading into tonight’s report, and where the actual risk lives. ## FY2025: The Growth Was Real $3.95 billion in revenue …
MTA at $6.62: Gold Royalty Without the Mining Risk Gold hit $4,700 an ounce this week. If you own a gold miner, you’re celebrating. You’re also exposed to diesel costs, labor disputes, equipment failures, and the fact that mining is genuinely hard. Metalla Royalty & Streaming (NYSE American: MTA) offers a cleaner trade. The company …
EVLV posted 45% Q1 revenue growth, raised 2026 guidance, and still trades at a discount because investors do not fully trust the story yet. Here is the bull case, the bear case, and the price range that still works.
Energy Vault grew Q1 revenue 156% and pushed backlog to $1.35 billion, but new secured convertibles make NRGV a tougher stock to chase above $5.
This CDNA stock analysis gets interesting fast: CareDx is a transplant diagnostics company that just put up $380 million in 2025 revenue, up 14% year over year, guided to $420 million to $444 million for 2026, and still trades at roughly 2.7 times sales. For a company with category leadership, real profitability, and an earnings …
Small-cap promotion trap checklist is the phrase I wish more retail investors searched before they chased the latest “hidden gem” in a Telegram room. In 2026, the scam is not always a pink-sheet boiler room anymore. Sometimes it looks like a slick Substack thread, a Discord callout, or a social feed full of screenshots that …